Although serum concentration of WISP1 before radiotherapy showed no significant difference between patients with or without tumor relapse (data not shown), significant elevation of WISP1 concentration was detected in relapsed patients (n=12) than in patients without relapse (n=15) (P=0.041) (Fig. 2D). This evidence concerns the gene CCN4 and neoplasm.